Invion Ltd (IVX) - Total Liabilities
Based on the latest financial reports, Invion Ltd (IVX) has total liabilities worth AU$1.24 Million AUD (≈ $876.08K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Invion Ltd - Total Liabilities Trend (2001–2025)
This chart illustrates how Invion Ltd's total liabilities have evolved over time, based on quarterly financial data. See IVX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Invion Ltd Competitors by Total Liabilities
The table below lists competitors of Invion Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Roolife Group Ltd
AU:RLG
|
Australia | AU$1.09 Million |
|
Traffic Technologies Ltd
AU:TTI
|
Australia | AU$33.99 Million |
|
CPT Global Ltd
AU:CGO
|
Australia | AU$5.43 Million |
|
AMMPOWER CORP.
F:601A
|
Germany | €8.36 Million |
|
Artelo Biosciences Inc
NASDAQ:ARTL
|
USA | $4.07 Million |
|
Vaxtex Cotfab Limited
NSE:VCL
|
India | Rs283.86 Million |
|
Atlantis S.A.
WAR:ATS
|
Poland | zł24.00K |
|
Westar Resources Ltd
AU:WSR
|
Australia | AU$114.20K |
Liability Composition Analysis (2001–2025)
This chart breaks down Invion Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see IVX stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.69 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Invion Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Invion Ltd (2001–2025)
The table below shows the annual total liabilities of Invion Ltd from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$1.24 Million ≈ $876.08K |
+22.13% |
| 2024-06-30 | AU$1.01 Million ≈ $717.34K |
+55.82% |
| 2023-06-30 | AU$650.62K ≈ $460.36K |
+40.70% |
| 2022-06-30 | AU$462.41K ≈ $327.19K |
-45.69% |
| 2021-06-30 | AU$851.50K ≈ $602.49K |
+160.54% |
| 2020-06-30 | AU$326.82K ≈ $231.25K |
-45.95% |
| 2019-06-30 | AU$604.71K ≈ $427.87K |
-75.24% |
| 2018-06-30 | AU$2.44 Million ≈ $1.73 Million |
+35.35% |
| 2017-06-30 | AU$1.80 Million ≈ $1.28 Million |
-69.89% |
| 2016-06-30 | AU$5.99 Million ≈ $4.24 Million |
-35.13% |
| 2015-06-30 | AU$9.24 Million ≈ $6.54 Million |
+102.10% |
| 2014-06-30 | AU$4.57 Million ≈ $3.23 Million |
-12.33% |
| 2013-06-30 | AU$5.21 Million ≈ $3.69 Million |
+539.38% |
| 2012-06-30 | AU$815.52K ≈ $577.03K |
-88.13% |
| 2011-06-30 | AU$6.87 Million ≈ $4.86 Million |
-25.82% |
| 2010-06-30 | AU$9.26 Million ≈ $6.56 Million |
-23.93% |
| 2009-06-30 | AU$12.18 Million ≈ $8.62 Million |
+88.43% |
| 2008-06-30 | AU$6.46 Million ≈ $4.57 Million |
+113.99% |
| 2007-06-30 | AU$3.02 Million ≈ $2.14 Million |
-66.86% |
| 2006-06-30 | AU$9.11 Million ≈ $6.45 Million |
-22.28% |
| 2005-06-30 | AU$11.73 Million ≈ $8.30 Million |
+505.68% |
| 2004-06-30 | AU$1.94 Million ≈ $1.37 Million |
+26.12% |
| 2003-06-30 | AU$1.53 Million ≈ $1.09 Million |
-11.98% |
| 2002-06-30 | AU$1.74 Million ≈ $1.23 Million |
+24.31% |
| 2001-06-30 | AU$1.40 Million ≈ $992.71K |
-- |
About Invion Ltd
Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also in… Read more